According to De Francesco et al. (2014) estrogenic GPER signaling is able to trigger hypoxia-inducible factor 1A (HIF1A)-dependent vascular endothelial growth factor (VEGF) expression that supports angiogenesis and progression in breast cancer (De Francesco et al. 2014). This evidence concerns the gene GPER1 and breast cancer.